No benefit of Clopidogrel Pretreatment in stable patients undergoing elective PCI

被引：0
|
作者：
Bellemain-Appaix, Anne [1 ]
O'Connor, Stephen A. [2 ]
Silvain, Johanne [3 ]
Cucherat, Michel [4 ]
Collet, Jean-philippe [3 ]
Bernasconi, Francois [1 ]
Montalescot, Gilles
机构：
[1] CH La Fontonne Antibes, Antibes, MS, France
[2] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
[3] Pitie Salpetriere, Paris, France
[4] Chu Lyon, Lyon, MS, France
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 62卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：B44 / B44
页数：1
相关论文
共 50 条
  • [21] Clopidogrel Bolus is Inferior to Sustained Clopidogrel Pretreatment in Patients Undergoing Carotid Artery Stent Placement
    Qureshi, Adnan I.
    Huang, Wei
    Lobanova, Iryna
    Ishfaq, M. Fawad
    French, Brandi R.
    Siddiq, Farhan
    Gomez, Camilo R.
    [J]. NEUROSURGERY, 2022, 90 (06) : 717 - 724
  • [22] Clopidogrel pretreatment in PCI: Absolute requirement or obsolete myth?
    Alexopoulos, Dimitrios
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 146 (03) : 305 - 310
  • [23] Superior effect of eptifibatide added to clopidogrel on biomarker expression detected by fluorokine multi-analyte profiling in patients undergoing elective PCI
    Gurbel, P. A.
    Bliden, K.
    Dichiara, J.
    Kreutz, R.
    Hamed, M.
    Bailon, O.
    Tantry, U. S.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 195 - 196
  • [24] Early benefit of cangrelor in patients undergoing PCI in CHAMPION PHOENIX
    Cavender, M.
    Harrington, R.
    Stone, G.
    Mahaffey, K.
    Skerjanec, S.
    Prats, J.
    Liu, T.
    Day, J.
    Deliargyris, E.
    Bhatt, D.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 136 - 136
  • [25] Efficacy and Safety of Double Dosage of Clopidogrel in AMI Patients with Low Response to Clopidogrel Undergoing Delayed PCI
    Fu, Xianghua
    Jia Xinwei
    Huang Jingjing
    Gu Xinshun
    Fan Weize
    Wu Weili
    Li Shiqiang
    Jiang Yunfa
    Liu Jinjun
    [J]. CIRCULATION, 2008, 118 (18) : S820 - S820
  • [26] RESISTANCE TO CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IS A NEGATIVE PROGNOSTIC FACTOR IN PATIENTS UNDERGOING ELECTIVE PCI FOR STABLE CORONARY ARTERY DISEASE: ANALYSIS FROM LABORATORY SUBSTUDY OF PRAGUE 8 TRIAL
    Petr, Robert
    Motovska, Zuzana
    Marinov, Iuri
    Bilkova, Danuse
    Widimsky, Petr
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [27] Clopidogrel loading dose in patients undergoing elective percutaneous coronary intervention Reply
    Siller-Matula, Jolanta M.
    Jilma, Bernd
    [J]. HEART, 2011, 97 (13) : 1111 - 1112
  • [28] Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI
    Laudani, Claudio
    Angiolillo, Dominick J.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (12) : 1422 - 1424
  • [29] HIGH LEVELS OF ASYMMETRIC DIMETHYL-ARGININE (ADMA) INCREASE RESIDUAL PLATELET REACTIVITY AFTER CLOPIDOGREL ADMINISTRATION IN PATIENTS UNDERGOING ELECTIVE PCI
    Nusca, Annunziata
    Di Giovanni, Giacomo
    Gatto, Laura
    Patti, Giuseppe
    D'Ambrosio, Andrea
    Contuzzi, Rocco
    Di Sciascio, Germano
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [30] Elevated plasma levels of asymmetric dimethylarginine (ADMA) are associated with high residual platelet reactivity after clopidogrel therapy in patients undergoing elective PCI
    Nusca, A.
    Di Giovanni, G.
    Gatto, L.
    Patti, G.
    Miglionico, M.
    Contuzzi, R.
    D'ambrosio, A.
    Battistoni, F.
    Dicuonzo, G.
    Di Sciascio, G.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 : 204 - 204
12345